Ligand validation:9AYI

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 9AYI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9AYI_NAD_A_605	95%	64%	0.063	0.966	0.65	0.73	-	1	0	0	100%	1
9AYI_NAD_D_605	82%	66%	0.095	0.949	0.66	0.66	-	1	1	0	100%	1
9AYI_NAD_B_602	76%	68%	0.089	0.924	0.66	0.58	-	-	0	0	100%	0.5
9AYI_NAD_C_605	75%	67%	0.091	0.922	0.61	0.65	-	-	1	0	100%	1
9AYI_NAD_B_605	74%	66%	0.109	0.938	0.67	0.65	-	1	2	0	100%	1
9AYI_NAD_C_604	72%	63%	0.113	0.937	0.68	0.72	-	1	3	0	100%	1
9AYI_NAD_D_603	30%	69%	0.149	0.812	0.61	0.58	-	-	0	0	100%	1
9AYI_NAD_A_601	25%	67%	0.174	0.809	0.66	0.62	-	-	1	0	100%	0.5
1PJ3_NAD_C_2601	87%	24%	0.096	0.967	1.86	1.3	11	2	1	0	100%	1
7BSJ_NAD_A_601	58%	44%	0.145	0.925	0.9	1.24	3	6	1	0	100%	1
7BSK_NAD_A_602	44%	47%	0.199	0.926	0.84	1.18	3	6	0	0	100%	1
7BSL_NAD_A_602	9%	48%	0.336	0.83	0.81	1.17	1	5	0	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.